INGENITO GARY

CIK 00012794732 companiesCORAL GABLES, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001279473

Recent Transactions

50 trades

Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-05-14$4.64/sh+44,000→ 112,873 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-05-14−44,000→ 546,282 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-05-14$23.63/sh−44,000→ 68,873 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-05-13$23.68/sh−200,000→ 68,873 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-05-13$3.42/sh+200,000→ 268,873 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-05-13−200,000→ 590,282 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-03-06$2.24/sh+180,096→ 248,969 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-03-06$21.67/sh−180,096→ 68,873 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-03-06−180,096→ 790,282 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-03-05$22.09/sh−44,904→ 68,873 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2025-03-05$2.24/sh+44,904→ 113,777 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-03-05−44,904→ 970,378 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-02-14−10,000→ 1,015,282 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-02-14+10,000→ 71,308 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-02-14−2,435→ 68,873 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-27−3,541→ 61,308 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-27+9,000→ 64,849 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-12-27−9,000→ 1,025,282 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-09+7,349→ 58,740 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-12-09−7,349→ 1,034,282 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-09−2,891→ 55,849 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-11-27−12,000→ 1,041,631 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-27$4.01/sh+12,000→ 63,391 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-27$22.67/sh−3,369→ 51,391 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-27$22.74/sh−8,631→ 54,760 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-11-21+125,696→ 1,038,271 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-11-21+15,360→ 1,053,631 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-11-20−38,000→ 912,575 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-20$21.20/sh−38,000→ 51,391 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-11-20$4.01/sh+38,000→ 89,391 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-08-09$18.04/sh−100,000→ 51,391 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-08-09$4.01/sh+100,000→ 151,391 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-08-09−100,000→ 950,575 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-06-05$4.01/sh+80,000→ 131,391 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2024-06-05−80,000→ 1,050,575 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2024-06-05$16.16/sh−80,000→ 51,391 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-02-15+10,000→ 53,826 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-02-15−10,000→ 1,130,575 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-02-15−2,435→ 51,391 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2023-12-27+9,000→ 47,367 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-12-27−9,000→ 1,140,575 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2023-12-27−3,541→ 43,826 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-12-08+22,049→ 1,149,575 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-12-08+153,526→ 1,127,526 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-12-06$14.02/sh−50,000→ 38,367 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2023-12-06−50,000→ 974,000 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common stock, par value $0.001 per share
2023-12-06$1.13/sh+50,000→ 88,367 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2023-02-15−2,435→ 38,367 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2023-02-15+10,000→ 1,024,000 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2023-02-15+10,000→ 40,802 total

Companies

Recent Filings

Address

355 ALHAMBRA CIRCLE, SUITE 801

CORAL GABLES, FL, 33134

View on SEC.gov